pcos and glp 1 The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome Weight Loss with PCOS Using
Description
22% of those who were told by a doctor that they are overweight or obese report having used GLP-1 medications
PMCID: PMC5373497
They: Slow digestion Increase satiety Regulate blood sugar Emerging research shows they also affect the brains reward system
Lingvay I, Catarig AM, Frias JP, et al
3 study initiation
[DOI] [PMC free article] [PubMed] [Google Scholar] 78.Lambadiari V., Thymis J., Kouretas D., Skaperda Z., Tekos F., Kousathana F., Kountouri A., Balampanis K., Parissis J., Andreadou I., et al
